<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39399822</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2213-4220</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Integrative medicine research</Title><ISOAbbreviation>Integr Med Res</ISOAbbreviation></Journal><ArticleTitle>Long-term follow-up of the treatment for severe COVID-19 with qigong exercise and acupressure: A randomized controlled trial.</ArticleTitle><Pagination><StartPage>101084</StartPage><MedlinePgn>101084</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101084</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.imr.2024.101084</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Most clinical trials have reported significant short-term effects of traditional medicine therapies on COVID-19 patients. However, there is no clinical trial to determine the long-term effects of traditional medicine therapies on severe COVID-19 patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 128 patients with severe COVID-19, who were recruited in our previous clinical trial following hospital discharge, were monitored at months 14 and 28. This trial aims to evaluate the long-term effect of an early Qigong exercise and acupressure rehabilitation program on patients with severe COVID-19.The intervention group received qigong exercise and acupressure therapy, plus standard therapies. The control group received standard therapies.The study was a single-center, parallel, randomized, prospective follow-up study. The outcomes of the study included changes in the modified Borg dyspnea scale (MBS), the modified Medical Research Council dyspnea scale (mMRC), the patient health questionnaire-9 scale (PHQ-9), the activity of daily living (ADL), the remaining clinical symptoms and any intervention related adverse events.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The intervention group showed a statistically significant improvement in the mMRC scores (-0.4, 95 % CI (-0.6, 0.2), <i>P</i> &lt; 0.001) and the MBS scores (-0.6, 95 % CI (-0.9, -0.3), <i>P</i> &lt; 0.001) after 14 months of discharge compared with the control group. At 28 months of discharge, the intervention group, compared with the control group alone, significantly increased their MBS scores (-0.4, 95 % CI (-0.7, -0.1), <i>P</i> = 0.024) and a significantly decreased positive rate of dyspnea symptoms after 14 months of discharge (<i>P</i> &lt; 0.05). However, ADL and PHQ-9 scores showed no significant difference between the two groups during the follow-up (<i>P</i> &gt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">QARP had long-term sustained efficacy for dyspnea, chest tightness, and cough in patients with COVID-19, especially in young and middle-aged patients, and the effect was significant at the 14th month of follow-up.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">This trial was registered at the China Clinical Trial Registry (ChiCTR2100044572).</AbstractText><CopyrightInformation>© 2024 Korea Institute of Oriental Medicine. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shuting</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Suzhou Hospital of Traditional Chinese Medicine, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ranran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Chongjie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Acupuncture-Moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Huangshi Hospital of Traditional Chinese Medicine, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jinxiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Integr Med Res</MedlineTA><NlmUniqueID>101612707</NlmUniqueID><ISSNLinking>2213-4220</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acupressure</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Qigong</Keyword><Keyword MajorTopicYN="N">Randomized controlled trial</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>7</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39399822</ArticleId><ArticleId IdType="pmc">PMC11465148</ArticleId><ArticleId IdType="doi">10.1016/j.imr.2024.101084</ArticleId><ArticleId IdType="pii">S2213-4220(24)00064-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J] Lancet. 2020;395(10223):497–506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Accessed 17 February 2023. https://Covid19.who.int/.</Citation></Reference><Reference><Citation>Yang X., Hou C., Shen Y., et al. Two-year health outcomes in hospitalized COVID-19 survivors in China. JAMA Netw Open. 2022;5(9) doi: 10.1001/jamanetworkopen.2022.31790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.31790</ArticleId><ArticleId IdType="pmc">PMC9478774</ArticleId><ArticleId IdType="pubmed">36107425</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng F., Tuchman S., Denninger J.W., Fricchione G.L., Yeung A. Qigong for the prevention, treatment, and rehabilitation of COVID-19 infection in older adults. Am J Geriatr Psychiatry. 2020;28(8):812–819. doi: 10.1016/j.jagp.2020.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7227578</ArticleId><ArticleId IdType="pubmed">32425471</ArticleId></ArticleIdList></Reference><Reference><Citation>Polkey M.I., Qiu Z.H., Zhou L., et al. Tai Chi and pulmonary rehabilitation compared for treatment-naive patients with COPD: a randomized controlled trial. Chest. 2018;153(5):1116–1124. doi: 10.1016/j.chest.2018.01.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2018.01.053</ArticleId><ArticleId IdType="pubmed">29625777</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao C.M., Zhuang Y.C. Efficacy of liuzijue qigong in individuals with chronic obstructive pulmonary disease in remission. J Am Geriatr Soc. 2015;63(7):1420–1425. doi: 10.1111/jgs.13478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13478</ArticleId><ArticleId IdType="pubmed">26131612</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi J., Yang W., Hao P., et al. WeChat as a platform for baduanjin intervention in patients with stable chronic obstructive pulmonary disease in China: retrospective randomized controlled trial. JMIR Mhealth Uhealth. 2021;9(2):e23548. doi: 10.2196/23548.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/23548</ArticleId><ArticleId IdType="pmc">PMC7886617</ArticleId><ArticleId IdType="pubmed">33528369</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H.S., Wu S.C., Lin J.G., Lin L.C. Effectiveness of acupressure in improving dyspnoea in chronic obstructive pulmonary disease. J Adv Nurs. 2004;45(3):252–259. doi: 10.1046/j.1365-2648.2003.02886.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2648.2003.02886.x</ArticleId><ArticleId IdType="pubmed">14720242</ArticleId></ArticleIdList></Reference><Reference><Citation>Qingguang Z., Shuaipan Z., Jingxian L.I., et al. Effectiveness of Liu-zi-jue exercise on coronavirus disease 2019 in the patients: a randomized controlled trial. J Tradit Chin Med. 2022;42(6):997–10053. doi: 10.19852/j.cnki.jtcm.2022.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.19852/j.cnki.jtcm.2022.06.009</ArticleId><ArticleId IdType="pmc">PMC9924758</ArticleId><ArticleId IdType="pubmed">36378059</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Jiang J., Shen P., et al. Liuzijue is a promising exercise option for rehabilitating discharged COVID-19 patients. Medicine (Baltimore) 2021;100(6):e24564. doi: 10.1097/MD.0000000000024564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000024564</ArticleId><ArticleId IdType="pmc">PMC7886442</ArticleId><ArticleId IdType="pubmed">33578552</ArticleId></ArticleIdList></Reference><Reference><Citation>Zha L., Xu X., Wang D., Qiao G., Zhuang W., Huang S. Modified rehabilitation exercises for mild cases of COVID-19. Ann Palliat Med. 2020;9(5):3100–3106. doi: 10.21037/apm-20-753.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-20-753</ArticleId><ArticleId IdType="pubmed">32787373</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S.T., Zhan C., Ma Y.J., et al. Effect of qigong exercise and acupressure rehabilitation program on pulmonary function and respiratory symptoms in patients hospitalized with severe COVID-19: a randomized controlled trial. Integr Med Res. 2021;10 doi: 10.1016/j.imr.2021.100796. Suppl.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imr.2021.100796</ArticleId><ArticleId IdType="pmc">PMC8553411</ArticleId><ArticleId IdType="pubmed">34733607</ArticleId></ArticleIdList></Reference><Reference><Citation>Junfang J., Yingchun H., Qiang L., Meng S. The effect of Liuzijue breathingexercises combined with acupoint massage on improving lung function and quality of life in elderly patients with COPD. Chin Mod Doct. 2019;57(27):100–103.</Citation></Reference><Reference><Citation>Zhang S., Zhu Q., Zhan C., et al. Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial. Trials. 2020;21(1):751. doi: 10.1186/s13063-020-04693-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-020-04693-5</ArticleId><ArticleId IdType="pmc">PMC7450683</ArticleId><ArticleId IdType="pubmed">32854761</ArticleId></ArticleIdList></Reference><Reference><Citation>Hygiene Emergency Office. Revision of "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Eighth Edition)" National Health Commission of the People's Republic of China home page 2020. https://www.nhc.gov.cn. Assessed by 15 March 2021.</Citation></Reference><Reference><Citation>Bestall J.C., Paul E.A., Garrod R., Garnham R., Jones P.W., Wedzicha J.A. Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi: 10.1136/thx.54.7.581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.54.7.581</ArticleId><ArticleId IdType="pmc">PMC1745516</ArticleId><ArticleId IdType="pubmed">10377201</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasui H., Inui N., Karayama M., et al. Correlation of the modified medical research council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease. Respir Med. 2019;146:76–80. doi: 10.1016/j.rmed.2018.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2018.11.020</ArticleId><ArticleId IdType="pubmed">30665522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendrick K.R., Baxi S.C., Smith R.M. Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs. 2000;26(3):216–222. doi: 10.1016/s0099-1767(00)90093-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0099-1767(00)90093-x</ArticleId><ArticleId IdType="pubmed">10839848</ArticleId></ArticleIdList></Reference><Reference><Citation>Levis B., Benedetti A., Thombs B.D. DEPRESsion screening data (DEPRESSD) collaboration. accuracy of patient health questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365:l1476. doi: 10.1136/bmj.l1476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l1476</ArticleId><ArticleId IdType="pmc">PMC6454318</ArticleId><ArticleId IdType="pubmed">30967483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Desveaux L., Janaudis-Ferreira T., Goldstein R., Brooks D. An international comparison of pulmonary rehabilitation: a systematic review. COPD. 2015;12(2):144–153. doi: 10.3109/15412555.2014.922066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15412555.2014.922066</ArticleId><ArticleId IdType="pubmed">24984085</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. The Who Global Report on Traditional and Complementary Medicine 2019 Is Released. Published 2019. Accessed Oct 01, 2022. https://www.who.int/news/item/20-05-2019-the-who-global-report-on-traditional-and-complementary-medicine-2019-is-released.</Citation></Reference><Reference><Citation>Araújo Oliveira Ana Luisa, Lília Andrade, Alda Marques. Minimal clinically important difference and predictive validity of the mMRC and mBorg in acute exacerbations of COPD[J] Eur Respiratory J. 2017;50(61) s.</Citation></Reference><Reference><Citation>Jones P.W., Beeh K.M., Chapman K.R., et al. Minimal clinically important differences in pharmacological trials[J] Am J Respir Crit Care Med. 2014;189(3):250–255.</Citation><ArticleIdList><ArticleId IdType="pubmed">24383418</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X.Y. Clinical efficacy of acupressure combined with traditional Chinese medicine application in the treatment of acute exacerbation of chronic obstructive pulmonary disease and its effect on inflammatory indexes. Chinese Folk Therapy. 2023;31(10):42–45. doi: 10.19621/j.cnki.11-3555/r.2023.1014.</Citation><ArticleIdList><ArticleId IdType="doi">10.19621/j.cnki.11-3555/r.2023.1014</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L.Y., Fang Y., Li Q. Clinical study of Xuanfei decoction combined with traditional Chinese medicine acupoint patch for the treatment of acute exacerbation of chronic obstructive pulmonary disease combined with respiratory failure. New Chinese Medicine. 2023;55(20):153–157. doi: 10.13457/j.cnki.jncm.2023.20.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.13457/j.cnki.jncm.2023.20.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Gao R., Wang Y., et al. Effect of Liuzijue on pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: study protocol for a multicenter, non-randomized, prospective study. BMC Complement Med Ther. 2022;22(1):296. doi: 10.1186/s12906-022-03789-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-022-03789-6</ArticleId><ArticleId IdType="pmc">PMC9670448</ArticleId><ArticleId IdType="pubmed">36397066</ArticleId></ArticleIdList></Reference><Reference><Citation>de Torres J.P., Pinto-Plata V., Ingenito E., et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest. 2002;121(4):1092–1098. doi: 10.1378/chest.121.4.1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.121.4.1092</ArticleId><ArticleId IdType="pubmed">11948037</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunjaya A., Poulos L., Reddel H., Jenkins C. Qualitative validation of the modified Medical Research Council (mMRC) dyspnoea scale as a patient-reported measure of breathlessness severity. Respir Med. 2022;203 doi: 10.1016/j.rmed.2022.106984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2022.106984</ArticleId><ArticleId IdType="pubmed">36179385</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssens J.P., Pache J.C., Nicod L.P. Physiological changes in respiratory func-tion associated with ageing. Eur Respir J. 1999;13(1):197–205. doi: 10.1034/j.1399-3003.1999.13a36.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-3003.1999.13a36.x</ArticleId><ArticleId IdType="pubmed">10836348</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowery E.M., Brubaker A.L., Kuhlmann E., Kovacs E.J. The aging lung. Clin Interv Aging. 2013;8:1489–1496. doi: 10.2147/CIA.S51152.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S51152</ArticleId><ArticleId IdType="pmc">PMC3825547</ArticleId><ArticleId IdType="pubmed">24235821</ArticleId></ArticleIdList></Reference><Reference><Citation>Damayanthi H.D.W.T., Prabani K.I.P. Nutritional determinants and COVID-19 outcomes of older patients with COVID-19: a systematic review. Arch Gerontol Geriatr. 2021;95 doi: 10.1016/j.archger.2021.104411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2021.104411</ArticleId><ArticleId IdType="pmc">PMC8010373</ArticleId><ArticleId IdType="pubmed">33836322</ArticleId></ArticleIdList></Reference><Reference><Citation>Bencivenga L., Rengo G., Varricchi G. Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition. Geroscience. 2020;42(4):1089–1092. doi: 10.1007/s11357-020-00218-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00218-9</ArticleId><ArticleId IdType="pmc">PMC7308600</ArticleId><ArticleId IdType="pubmed">32578073</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W.J., Hui C.K.M., Hull J.H., et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021;9(5):533–544. doi: 10.1016/S2213-2600(21)00125-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00125-9</ArticleId><ArticleId IdType="pmc">PMC8041436</ArticleId><ArticleId IdType="pubmed">33857435</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO Director-General's opening remarks at the media briefing. Accessed 17 February 2023. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing, 5-may-2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>